Comparative sequence analysis of patient-matched primary colorectal cancer, metastatic, and recurrent metastatic tumors after adjuvant FOLFOX chemotherapy

Table 1 Patient characteristics

Case	Age range	Sex	Primary site	Histopathological type	Metastatic site (Pre−/Post-FOLFOX)	FOLFOX cycles	DFS (days)	Days from end of FOLFOX until recurrence
1	65–69	Male	S	Mode	Liver	4	97	−16^a
2	65–69	Male	Rs-S	Well	Liver	9	109	−88^a
3	60–64	Female	Rs	Mode	Liver	11	328	120
4	65–69	Female	Rb	Well	Lung	12	556	264

S sigmoid colon, Rs rectosigmoid, Rb rectum below the peritoneal reflection
Mode Moderately differentiated adenocarcinoma, Well Well-differentiated adenocarcinoma
DFS Disease-free survival
^aFOLFOX administered after recurrence

ISSN: 1471-2407